发明名称 ANTI-PCSK9 INHIBITORY ANTIBODIES FOR TREATING PATIENTS WITH HYPERLIPIDEMIA UNDERGOING LIPOPROTEIN APHERESIS
摘要 The present invention provides methods for reducing or eliminating a patient's need for lipoprotein apheresis therapy. The methods of the present invention comprise administering to a patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody. The methods of the present invention are useful for treating patients with hyperlipidemia and related conditions who are currently being treated with a therapeutic regimen comprising lipoprotein apheresis (e.g., LDL apheresis or Lp(a) apheresis).
申请公布号 WO2017031151(A1) 申请公布日期 2017.02.23
申请号 WO2016US47257 申请日期 2016.08.17
申请人 REGENERON PHARMACEUTICALS, INC. 发明人 PORDY, Robert C.;MANVELIAN, Garen
分类号 C07K16/40;A61K39/00;A61K39/395;A61P3/06 主分类号 C07K16/40
代理机构 代理人
主权项
地址